PROCEPT BioRobotics (PRCT) Operating Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Operating Expenses for 7 consecutive years, with $89.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 21.42% year-over-year to $89.8 million in Q2 2026; TTM through Jun 2026 was $330.9 million, a 23.34% increase from a year earlier, with the FY2025 full-year figure at $300.1 million, up 28.4% from the prior year.
• Operating Expenses was $89.8 million for Q2 2026 at PROCEPT BioRobotics, up from $86.6 million in the prior quarter.
• Over five years, Operating Expenses peaked at $89.8 million in Q2 2026 and troughed at $23.4 million in Q1 2022.
• A 5-year average of $56.0 million and a median of $55.5 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 89.8% in 2022 and advanced 20.89% in 2026, its largest moves.
• Over 5 years, Operating Expenses stood at $35.7 million in 2022, then jumped by 42.27% to $50.8 million in 2023, then increased by 24.74% to $63.4 million in 2024, then rose by 22.04% to $77.4 million in 2025, then increased by 16.05% to $89.8 million in 2026.
• The last three Operating Expenses figures came in at $89.8 million (Q2 2026), $86.6 million (Q1 2026), and $77.4 million (Q4 2025), per Business Quant data.